Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here.
You are subscribed to Ophthalmology Times Europe.
Ophthalmology Times Europe E-News
Powered by Modern Medicine
 
 
 
 
In this issue
IOLs
Retina
Glaucoma
 
 
Survey

Which IOLs are most popular in your practice?

Please click here to vote

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Felicity Thomas, editor.


January 14, 2015
Implanting two IOLs
Implanting two different IOLs benefits some patients
Ophthalmologists seeking improved binocular visual acuity (VA) curve and spectacle independence for their patients can implant diffractive multifocal IOLs (MIOLs) of differing addition power without compromising contrast sensitivity and stereopsis. More...
Systemic bevacizumab
No ill effects from systemic bevacizumab in cancer patients
Systemic bevacizumab did not have a detrimental effect on the healthy eyes of cancer patients in a recent study . More...
Supplements for POAG
Supplements offer no short-term benefit for POAG
Oral antioxidant supplements don't appear to offer short-term benefit to those with mild or moderate primary open-angle glaucoma (POAG), researchers from Spain report. More...
Product Profile
Essential Line from ZEISS
Simplicity in basic diagnostics
The new ZEISS Essential Line portfolio of basic diagnostic instruments brings simplicity to your examination workflows – and quality right from
the start.
Read more
Challenging our Treatment Approach in AMD
The increasing importance of regimen and practicality. Read more